AngioDynamics, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
AngioDynamics, Inc. (ANGO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $21.91 per share for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-07-14
- AngioDynamics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2026 was $21.91, a 32.31% increase from fiscal 2025.
- AngioDynamics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $16.56, a 3.50% decline from fiscal 2024.
- AngioDynamics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $17.16, a 14.29% decline from fiscal 2023.
- AngioDynamics, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $20.02, a 25.83% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2026-05-31 | $21.91 10-K · filed 2026-07-14 |
| 2025-05-31 | $16.56 10-K · filed 2025-07-18 |
| 2024-05-31 | $17.16 10-K · filed 2024-07-25 |
| 2023-05-31 | $20.02 10-K · filed 2023-08-03 |
| 2022-05-31 | $15.91 10-K · filed 2022-07-22 |
| 2021-05-31 | $18.38 10-K · filed 2021-07-27 |
| 2020-05-31 | $17.81 10-K · filed 2020-08-10 |
| 2019-05-31 | $17.52 10-K · filed 2019-07-25 |
| 2018-05-31 | $16.24 10-K · filed 2018-07-23 |
| 2017-05-31 | $16.03 10-K · filed 2017-08-04 |
| 2016-05-31 | $13.85 10-K · filed 2016-08-01 |
| 2015-05-31 | $14.71 10-K · filed 2015-08-10 |
| 2014-05-31 | $17.45 10-K · filed 2015-01-12 |
| 2013-05-31 | $17.45 10-K · filed 2015-01-12 |
| 2012-05-31 | $14.22 10-K · filed 2015-01-12 |
| 2011-05-31 | $17.94 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |